Abstract
EARLY STAGE Follicular Lymphoma: First Results of the FIL “Miro” Study, a Multicenter Phase II Trial Combining Local Radiotherapy and MRD-Driven Immunotherapy
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have